상세 보기
- Choi, Yeon A.;
- Park, Jeong Su;
- Park, Mi Young;
- Oh, Ki Sook;
- Lee, Myung Sok;
- ... Kim, Keun Il;
- ... Yang, Young;
- 외 5명
WEB OF SCIENCE
50SCOPUS
51초록
The cancerous inhibitor of protein phosphatase 2A (CIP2A) increases the migration and metastasis of various cancer cells. Overexpression of CIP2A has been shown to increase the proliferation of MDA-MB-231 cells. We thus assessed whether CIP2A expression is associated with sensitivity to doxorubicin. MDA-MB-231 cells showed an increase in CIP2A expression after treatment with doxorubicin, while MCF-7 cells showed a decrease in CIP2A expression. The overexpression of CIP2A in MCF-7 cells overcame the inhibition of cell proliferation in response to doxorubicin treatment. CIP2A expression was not affected by wild-type or mutant p53. However, mutant p53 blocked doxorubicin-mediated CIP2A down-regulation in HCT116 cells. As a regulation mechanism of doxorubicin-mediated CIP2A expression, we showed that phosphorylated Akt was involved in the suppression of CIP2A expression. (C) 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
키워드
- 제목
- Increase in CIP2A expression is associated with doxorubicin resistance
- 저자
- Choi, Yeon A.; Park, Jeong Su; Park, Mi Young; Oh, Ki Sook; Lee, Myung Sok; Lim, Jong-Seok; Kim, Keun Il; Kim, Kun-yong; Kwon, Junhye; Yoon, Do Young; Moon, Eun-Yi; Yang, Young
- 발행일
- 2011-03
- 유형
- Article
- 저널명
- FEBS Letters
- 권
- 585
- 호
- 5
- 페이지
- 755 ~ 760